Injective Partners with BDACS for Won-Backed Tokenized Asset Settlement
Injective and BDACS will use the KRW1 stablecoin for settling tokenized assets on Injective's platform.
Injective and BDACS will use the KRW1 stablecoin for settling tokenized assets on Injective's platform. Injective (INJ) is trading at ₹860 ($9.05), up 2.4% since this brief published. This is an original Token Times brief based on reporting by Cryptopolitan, with live market data added, as of Tue, 20 Oct 2026 22:45:01 UTC.
This partnership provides Korean institutions with a local currency option for trading tokenized assets, reducing dependency on dollar stablecoins and potentially boosting adoption of tokenized assets in South Korea.
- Injective and BDACS partner to use KRW1 stablecoin for tokenized asset settlement.
- Partnership aims to provide Korean institutions with a won-based trading option.
- INJ token price up 3.82% in 24 hours following the announcement.
- Injective's Real-World Asset Perpetuals Surpass $1.1 Billion in Trading Volume
- Injective Partners with BDACS for Korean Won Stablecoin Integration
- Injective Partners with BDACS for Won-Backed Tokenized Asset Settlement — this brief
Injective, a blockchain platform for decentralized finance applications, has entered into a partnership with BDACS, a South Korean digital asset custody firm, to integrate the won-backed stablecoin KRW1 into its network.
Under the agreement, KRW1 will serve as the primary settlement asset for tokenized real-world assets on Injective's platform, offering Korean institutions a local currency option for trading tokenized assets.
The announcement, made on October 20, 2026, marks a significant step in providing an alternative to dollar-denominated stablecoins, which have traditionally dominated the market for tokenized asset trading.
This development comes at a time when the total cryptocurrency market cap stands at $2.84 trillion, with 
Bitcoin leading the charge at a 24-hour increase of 1.08%. The Fear & Greed Index is at 55, indicating a state of 'Greed' in the market.
Injective's native token, INJ, has seen a 3.82% increase in the past 24 hours and an 8.21% increase over the past week, reflecting positive market sentiment following the announcement.
Since this brief published about 1 hour ago, Injective (INJ) has moved from ₹840.26$8.84 to ₹860.23$9.05 — +2.38%.
The chart plots INJ's price: grey is the move before this brief published, the vertical dashed line marks the moment it published, the horizontal dashed line is the price then, and the coloured area is the move since — from Token Times's market data (daily resolution). It shows what happened after the news, not that the news caused it; many factors move prices. Not financial advice.
At today's peer-to-peer rate, 1 INJ ≈ ₹939.57 (about $9.05), up 4.8% over 24 hours. The rupee itself trades about 9.2% above the official rate on the P2P market, so a Indian buyer's effective cost differs from the headline dollar price.
Live market data
Current prices for the asset in this story — live, source-stamped, updated every 15 minutes.
Figures and sectors in this story, checked live against on-chain aggregators · October 20, 2026.
Token Times reads these figures directly from on-chain aggregators (DeFiLlama, mempool.space) at build time — independent of what any outlet reported. Sector totals aggregate every protocol DeFiLlama tracks in that category. Values are live and will change.
Injective Partners with BDACS for Won-Backed Tokenized Asset — questions & answers
What is the purpose of the Injective-BDACS partnership?
The partnership aims to facilitate won-denominated trading of tokenized assets, providing Korean institutions with a local currency option.
How will the KRW1 stablecoin be used?
The KRW1 stablecoin will serve as the primary settlement asset for tokenized real-world assets on Injective's platform.
What is the significance of this partnership for the market?
This partnership could boost the adoption of tokenized assets in South Korea by offering a local currency option, potentially reducing reliance on dollar stablecoins.
How much is 1 Injective worth in rupee today?
About ₹939.57 at the live peer-to-peer (P2P) USDT rate, which is what Indians typically trade at — equivalent to roughly $9.05. The rupee price moves with both INJ's US-dollar price and the USDT/INR rate; use our Injective in rupee page for any amount.
Has Injective's price moved since this brief was published?
INJ is up 2.38% since this brief first published — trading at ₹860 ($9.05) now versus ₹840 ($8.84) at publication. Token Times re-checks this figure against CoinGecko and Binance every 15 minutes.
Which outlets reported this story?
This is an original Token Times brief that synthesises reporting from Cryptopolitan. It is not a copy of any one article — follow the source links above for the original reporting.
Original summary — not financial advice. This is an original Token Times brief that summarises a development reported elsewhere and adds live market data for context; it is not the original article and reproduces no part of it. Follow the source link above for full details. Crypto is volatile and high-risk — always do your own research.